NYU Langone Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).

1,164 total trials 197 currently recruiting 741 completed early-phase tilt top decile by trial count

NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.

NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.

Top-decile sponsor footprint

NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 53/100

741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,164 total, page 10 of 24

COMPLETED Phase 1

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

NCT04503616
COMPLETED NA

TeleRehabilitation Following Arthroscopic Rotator Cuff Repair

NCT04541953
COMPLETED NA

Mapping the Target for the MRgFUS Treatment of Tremor

NCT04661241
COMPLETED Phase 2

BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)

NCT04494646
COMPLETED NA

Knotless Suture in Revision Total Joint Arthroplasty

NCT04403919
COMPLETED Early Phase 1

Effect of a High Citrate Beverage on Urine Chemistry in Urinary Stone Disease

NCT04697706
COMPLETED NA

Crutch Use After Arthroscopic Hip Surgery

NCT04070430
COMPLETED NA

SLAP Repair vs. Biceps Tenodesis in Patients Under 30: A Randomized Clinical Trial

NCT04494932
TERMINATED NA

Tenodesis vs. Self-locking Tenotomy in Long Head of the Biceps Tendon Lesions: A Randomized Clinical Trial

NCT04468906
COMPLETED NA

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

NCT04533880
COMPLETED Phase 2

R33: Levetiracetam in Early Psychosis

NCT04317807
COMPLETED NA

SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer

NCT04411810
COMPLETED Phase 4

An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery

NCT04522206
COMPLETED Phase 4

CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

NCT04369664
COMPLETED NA

Locus-coeruleus Function in Normal Elderly and AD Risk

NCT04403165
COMPLETED

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

NCT04517695
COMPLETED NA

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression

NCT04366258
COMPLETED Phase 4

Transmuscular Quadratus Lumborum Block Plus Pericapsular Injection vs Pericapsular Injection

NCT04353414
COMPLETED NA

Scaling Community-Clinical Linkage Models to Address Diabetes and Hypertension Disparities in the Southeast United States

NCT04263311
COMPLETED NA

The Effects of Perioperative Nutritional Optimization on Blood Markers

NCT04464161
COMPLETED Phase 3

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

NCT03945175
COMPLETED NA

Oral Pathology Asynchronous Telementoring Pilot Study

NCT04166214
COMPLETED NA

Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)

NCT04114669
COMPLETED

Electronic Triggers: Messaging After A1C EHR Alert

NCT04869319
COMPLETED Early Phase 1

Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.

NCT04520984
COMPLETED NA

Parenteral Nutrition Light Protection and Premature Outcomes

NCT04525872
COMPLETED NA

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

NCT04632238
COMPLETED NA

A Pilot Proof of Concept, Randomized Controlled, Single-Center Study of a Decision Aid Tool for Older Patients Considering LHC as Treatment for NSTEMI

NCT04270630
COMPLETED

TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

NCT04450992
COMPLETED NA

Mobile Attentional Bias Modification Training in Pediatric MS

NCT04441229
COMPLETED NA

Eponychial Stent Study

NCT04409093
COMPLETED

Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

NCT04570488
COMPLETED NA

Improving Physical, Mental, and Spiritual Health in Faith-Based Settings Through Creating a Healthy Culture in Bronx, NY

NCT04353427
COMPLETED Phase 2

CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients

NCT04364737
TERMINATED Phase 2

Treating COVID-19 With Hydroxychloroquine (TEACH)

NCT04369742
COMPLETED Phase 2

Cardiovascular Effects of COVID-19

NCT04365699
TERMINATED NA

Hyperbaric Oxygen for COVID-19 Patients

NCT04332081
COMPLETED Phase 2

COVID-19 PrEP HCW HCQ Study

NCT04354870
COMPLETED Phase 2

A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection

NCT04343989
COMPLETED NA

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

NCT04218201
COMPLETED NA

Patient Satisfaction With Virtual Post Operative Visits: Hip Arthroscopy

NCT04302077
COMPLETED

CTCs in Cervix Cancer

NCT04064515
COMPLETED Early Phase 1

Bronchoscopic Cryo-Immunotherapy of Lung Cancer

NCT04049474
COMPLETED NA

Heart Transplantation Using Normothermic Regional Perfusion Donation After Circulatory Death

NCT04284319
TERMINATED Phase 3

High Dose Oxytocin Nasal Spray for Treatment of Tinnitus

NCT04210310
TERMINATED Phase 4

Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support

NCT04080908
COMPLETED NA

Rehabilitation at Home Using Mobile Health In Older Adults After Hospitalization for Ischemic Heart Disease

NCT03978130
COMPLETED NA

Clinical Reminder Changes to Increase Smoking Cessation Treatment in Outpatient Psychiatry

NCT04071795
COMPLETED NA

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)

NCT04175977
COMPLETED NA

Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures

NCT03943329
← Previous Page 10 of 24 Next →

Phase Distribution

PhaseTrial count
Phase 1 99
Phase 2 132
Phase 3 28
Phase 4 95

Therapeutic Areas

Prostate Cancer 12
Breast Cancer 11
Multiple Sclerosis 9
Hypertension 8
Cardiovascular Diseases 8
Attention Deficit Hyperactivity Disorder 7
Depression 7
Epilepsy 7
Opioid Use Disorder 7
Coronary Artery Disease 6

What is open in the NYU Langone Health pipeline

197 recruiting of 1,164 indexed (17% open); 741 completed (64%).

Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

NYU Langone Health: open-pipeline peers nationwide

Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 15%16%17%18%19% Total trials Recruiting share NYU Langone HealthUniversity of Alabama at BirminghamWake Forest University Health SciencesEmory UniversityNorthwestern UniversityCSL BehringPenn State UniversityUniversity of HawaiiUniversity of Utah
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,164 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this NYU Langone Health page

1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.

  • 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.